BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31533941)

  • 1. A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer.
    Zhang Y; Zhou CK; Rencsok EM; Fall K; Lotan TL; Loda M; Giunchi F; Platz EA; De Marzo AM; Mucci LA; Fiorentino M; Ebot EM
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2047-2054. PubMed ID: 31533941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer.
    Davidsson S; Fiorentino M; Andrén O; Fang F; Mucci LA; Varenhorst E; Fall K; Rider JR
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2280-7. PubMed ID: 21953116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.
    Downer MK; Kenfield SA; Stampfer MJ; Wilson KM; Dickerman BA; Giovannucci EL; Rimm EB; Wang M; Mucci LA; Willett WC; Chan JM; Van Blarigan EL
    J Clin Oncol; 2019 Jun; 37(17):1499-1511. PubMed ID: 31026211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
    Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
    Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
    Ahearn TU; Pettersson A; Ebot EM; Gerke T; Graff RE; Morais CL; Hicks JL; Wilson KM; Rider JR; Sesso HD; Fiorentino M; Flavin R; Finn S; Giovannucci EL; Loda M; Stampfer MJ; De Marzo AM; Mucci LA; Lotan TL
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26615022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.
    Pernar CH; Ebot EM; Pettersson A; Graff RE; Giunchi F; Ahearn TU; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Stopsack KH; Gazeeva E; Lis RT; Parmigiani G; Rimm EB; Finn SP; Giovannucci EL; Fiorentino M; Mucci LA
    Eur Urol; 2019 Jul; 76(1):33-40. PubMed ID: 30301696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.
    Ahearn TU; Tchrakian N; Wilson KM; Lis R; Nuttall E; Sesso HD; Loda M; Giovannucci E; Mucci LA; Finn S; Shui IM
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2520-7. PubMed ID: 27115058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer.
    Giunchi F; Jordahl K; Bollito E; Colecchia M; Patriarca C; D'Errico A; Vasuri F; Malvi D; Fornari A; Bonetti LR; Corti B; Papotti M; DeGiuli P; Loda M; Montironi R; Fiorentino M; Rider JR
    Virchows Arch; 2017 Jun; 470(6):711-715. PubMed ID: 28405833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
    Karakiewicz PI; Benayoun S; Bégin LR; Duclos A; Valiquette L; McCormack M; Bénard F; Saad F; Perrotte P
    Int J Clin Pract; 2007 Mar; 61(3):425-30. PubMed ID: 17313610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer.
    Gerke T; Beltran H; Wang X; Lee GM; Sboner A; Karnes RJ; Klein EA; Davicioni E; Yousefi K; Ross AE; Börnigen D; Huttenhower C; Mucci LA; Trock BJ; Sweeney CJ
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):584-590. PubMed ID: 30420441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment.
    Sanchez A; Schoenfeld JD; Nguyen PL; Fiorentino M; Chowdhury D; Stampfer MJ; Sesso HD; Giovannucci E; Mucci LA; Shui IM
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):197-201. PubMed ID: 26926928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 24-year prospective study of dietary α-linolenic acid and lethal prostate cancer.
    Wu J; Wilson KM; Stampfer MJ; Willett WC; Giovannucci EL
    Int J Cancer; 2018 Jun; 142(11):2207-2214. PubMed ID: 29315549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study.
    MacLennan GT; Eisenberg R; Fleshman RL; Taylor JM; Fu P; Resnick MI; Gupta S
    J Urol; 2006 Sep; 176(3):1012-6. PubMed ID: 16890681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.
    Downer MK; Allard CB; Preston MA; Wilson KM; Kenfield SA; Chan JM; Mucci LA; Giovannucci E; Stampfer MJ
    Eur Urol Oncol; 2019 Mar; 2(2):126-134. PubMed ID: 31017087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
    Wang W; Bergh A; Damber JE
    APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer.
    Sutcliffe S; Giovannucci E; De Marzo AM; Leitzmann MF; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2160-6. PubMed ID: 17119041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of the asymptomatic prostatic inflammation in the development of prostate cancer].
    Molimard B; Camparo P; Desfemmes FR; Durand X; Haus R; Deligne E; Houlgatte A; Compérat E
    Prog Urol; 2010 Jul; 20(7):508-14. PubMed ID: 20656273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatitis as a risk factor for prostate cancer.
    Roberts RO; Bergstralh EJ; Bass SE; Lieber MM; Jacobsen SJ
    Epidemiology; 2004 Jan; 15(1):93-9. PubMed ID: 14712152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study.
    Platz EA; Drake CG; Wilson KM; Sutcliffe S; Kenfield SA; Mucci LA; Stampfer MJ; Willett WC; Camargo CA; Giovannucci E
    Int J Cancer; 2015 Aug; 137(4):949-58. PubMed ID: 25648070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.